Open AccessHER2 mutations in Chinese patients with non-small cell lung cancer
Author(s) -
Zhengbo Song,
Xinmin Yu,
Zhiyong Shi,
Jun Zhao,
Yiping Zhang
Publication year - 2016
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.11313
Subject(s) - medicine , lung cancer , cancer research , cancer , oncology , mutation , pathology , genetics , biology , gene
ERBB2 (HER2) is a driver gene identified in non-small cell lung cancer (NSCLC). The prevalence, clinicopathology, genetic variability and treatment of HER2-positive NSCLC in Chinese population are unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom